Rob Fenton

Rob Fenton has a diverse work experience spanning various industries and roles. Rob is the Director and Founder of Iceni Labs, an innovation commercialization enterprise, since March 2013. In this role, they combine commercial expertise with academic excellence across different sectors, including Defense and Security, Energy, Health, and Consumer.

Additionally, Rob has served as a Director at Pangaea Power Ltd since August 2014 and at Fair Air Limited since October 2020.

In the past, they worked as a Consultant at Biota Holdings from 1992 to May 2015, where they provided expertise in the field.

Rob also worked as a Life Sciences Consultant at Oury Clark from 2010 to 2014.

Furthermore, they served as a Director at Vorpal Technologies Ltd from March 2012 to March 2013.

Rob had roles as a Consultant at Imperial College London and Interim Business Development Manager at The Wellcome Trust from 2010 to 2012.

Prior to that, Rob worked as the R&D Director at Imperial College London's Institute of Biomedical Engineering from 2004 to 2010.

Rob also worked at GlaxoSmithKline, where they served as Acting Departmental Head Virology from 2002 to 2004 and as Virology Section Head from 1995 to 2002.

Rob Fenton completed their Bachelor of Science degree in Medical Microbiology and Bacteriology from the University of Leeds from 1968 to 1972. Rob then pursued their PhD in Virology from The University of Sheffield and completed it from 1974 to 1977.